Find uplifting stories about heroes, innovations, and solutions
8 results for "dmt"
Scientists discovered that a single dose of the psychedelic compound DMT produces longer-lasting antidepressant effects in mice than the currently approved rapid-acting treatment S-ketamine. This breakthrough could offer new hope for millions struggling with treatment-resistant depression.
A groundbreaking clinical trial shows one dose of the psychedelic DMT significantly reduced depression symptoms for up to six months. For millions who haven't found relief from traditional treatments, this research opens a promising new door.
A groundbreaking trial in London shows that DMT, the shortest-acting psychedelic drug, helped nearly half of depression patients feel better within just one week. The fast-acting treatment could transform care by letting patients go home hours after treatment instead of days.
A clinical trial found that one dose of DMT, a natural psychedelic compound, significantly reduced depression symptoms for up to three months. The short treatment session could make mental health care more accessible for millions who don't respond to traditional antidepressants.
A single dose of DMT, a natural compound in ayahuasca, rapidly reduced depression symptoms in a clinical trial and kept working for weeks. Scientists say the fast-acting treatment could help millions for whom current medications don't work.
A groundbreaking trial in the UK found that a single dose of DMT paired with therapy rapidly reduced depression symptoms in patients, with improvements lasting at least three months. Nearly half the participants achieved remission, opening new hope for faster, more accessible mental health treatment.
A brief 25-minute psychedelic treatment lifted depression symptoms that lasted up to six months for people who hadn't found relief anywhere else. Just one dose of DMT helped patients who'd been struggling for an average of 10 years.
Brazilian scientists discovered that one dose of the psychedelic DMT reversed depression symptoms in stressed mice better than 30 days of daily antidepressants. The breakthrough could lead to faster-acting treatments for severe depression.